Device Trial Radar · NCT07911163
Clinical Health Outcomes Evaluation of Terumo Aortic Hybrid Devices
Last checked: Nov 20, 2026Latest source record: Nov 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
150
Planned (sponsor's estimate)
Start
May 2027
Primary completion
May 2039
Study completion May 2039
Sponsor
- Lead sponsor
- Vascutek Ltd.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Nov 2, 2026
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This prospective, non-interventional, study of Thoraflex Hybrid devices is part of Terumo Aortic's clinical development and Post Market Clinical Follow-Up (PMCF) plan and will provide insights into both the short- and long-term clinical outcomes of all commercially available Thoraflex Hybrid devices.
Conditions
- Aortic Aneurysm and Dissection
Interventions
Thoraflex HybridDevice
Aortic repair with Thoraflex Hybrid device.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary EndpointTime frame: 1 year
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.